New Delhi: The inoculation of children in the age group of 12 to 14 years against COVID-19 started on Wednesday with the Corbevax vaccine.
Besides, the government has also decided to waive the condition of comorbidity for those above 60 years in order to receive the precaution dose.
“Taking the COVID-19 vaccination campaign forward, under the ‘ #SabkoVaccineMuftVaccine’ campaign led by PM @NarendraModi ji, the COVID vaccination of children in the age group of 12-14 has started from today. All people of 60+ age will also be able to get precaution dose from today. Let’s secure the country together, get the vaccine,” Health Minister Mansukh Mandaviya tweeted.
Two doses of Biological E’s intramuscular vaccine Corbevax would be administered to the beneficiaries in the 12 to 14 years age group in an interval of 28 days, the guidelines said.
As of March 01, 2021, there were 4.7 crore children aged 12 and 13 years in the country.
Also, the precaution dose can now be administered to all people aged 60 years and above, and the prioritisation and sequencing of this dose would be based on completion of nine months to 39 weeks from the date of administration of the second dose.
As per the guidelines, the precaution dose should be of the same vaccine that was administered to a person during primary vaccination.
“The vaccination slots will be booked for 12-14 years age group for “CorBEvax” only through Co-WIN. Vaccinator has to ensure that the vaccine is administered to only those children who have completed the age of 12 years on the date of vaccination and if a child is registered but has not attained the age of 12 years, the vaccination is not to be given,” the guidelines released by the Health ministry on Monday said.
The children eligible for vaccination can register through an existing account of a family member on Co-WIN or by creating a new account through a unique mobile number (this facility is available for all eligible citizens presently), it said.
The Centre has asked states to organise dedicated COVID-19 vaccination sessions through earmarked centres and train vaccinators to avoid mixing of vaccines during the inoculation of adolescents.
The states were also advised to ensure judicious utilisation of available COVID-19 vaccines.
